— Know what they know.
Not Investment Advice
Also trades as: GXGX (NASDAQ) · $vol 6M · GXGXW (NASDAQ) · $vol 0M · CELUW (NASDAQ) · $vol 0M

CELU NASDAQ

Celularity Inc.
1W: +15.9% 1M: -14.0% 3M: +100.0% YTD: +32.2% 1Y: -21.6% 3Y: -31.3% 5Y: -97.9%
$1.60
+0.22 (+15.94%)
 
Weekly Expected Move ±15.4%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 49 · $46.3M mcap · 19M float · 0.714% daily turnover · Short 68% of daily vol

Cash Flow Trends

Operating Cash Flow
-$6M +83.5% ▲
Capital Expenditures
$161K +96.0% ▲
5Y CAGR: +783.0%
Free Cash Flow
-$7M +84.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$814K +104.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$208M-$100M$14M-$196M-$58M
Depreciation & Amort.$8M$9M$9M$11M$8M
Stock-Based Comp.$4M$40M$16M$15M$12M
Change in Working Capital$4M-$6M-$15M-$7M$22M
Other Non-Cash Items$137M-$53M-$162M$138M$10M
Operating Cash Flow-$63M-$110M-$138M-$39M-$6M
— Investing Activities —
Capital Expenditures-$28M-$6M-$5M-$4M-$161K
Acquisitions (Net)$15M$0$0$0-$2M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$300K$0$0$2M
Investing Cash Flow-$13M-$6M-$5M-$4M$514K
— Financing Activities —
Net Debt Issuance$0$0$39M$11M$7M
Stock Repurchased-$256K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$265K$98M$27M$7M-$459K
Financing Cash Flow$102M$99M$120M$24M$7M
Net Change in Cash$26M-$17M-$23M-$19M$814K
Cash End of Period$70M$52M$29M$10M$11M
Free Cash Flow-$91M-$116M-$143M-$43M-$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms